logo
Michigan boy's death raises concerns about unregulated hyperbaric oxygen therapy outside of health care facilities

Michigan boy's death raises concerns about unregulated hyperbaric oxygen therapy outside of health care facilities

NBC News16-03-2025

The death of a 5-year-old in a hyperbaric chamber in Michigan has prompted calls for more oversight of hyperbaric oxygen therapy in the largely unsupervised wellness industry before another tragedy occurs.
Thomas Cooper was killed Jan. 31 when a fire broke out in a hyperbaric chamber at the Oxford Center, an alternative medicine clinic in the Detroit suburb of Troy. On Monday, the Oxford Center founder and CEO and three of her employees were charged in Thomas' death.
Hyperbaric chambers are pressurized, tubelike devices that people lie or sit in for treatment, depending on the type of chamber. The therapy involves breathing in air that consists of 100% oxygen, which helps the body heal more quickly but also creates a highly combustible environment. The treatment method has been cleared by the Food and Drug Administration to help over a dozen conditions including carbon monoxide poisoning, severe wounds and decompression sickness in scuba divers.
The Oxford Center's website lists over 100 conditions it says it treats, including many that the FDA has not approved for hyperbaric oxygen therapy, such as cancer, dyslexia, Alzheimer's, Lyme disease and autism — though it is not illegal to use hyperbaric chambers for these purposes. In a statement to NBC News, an attorney for the Oxford Center said the center was 'disappointed' by the charges filed against four staff members.
'The timing of these charges is surprising, as the typical protocol after a fire-related accident has not yet been completed. There are still outstanding questions about how this occurred,' Sam Vitale said via email about Thomas' death.
Thomas was receiving hyperbaric oxygen therapy for sleep apnea and attention-deficit/hyperactivity disorder, according to his family's attorney, which are not among the conditions approved by the FDA for such treatment. Michigan Attorney General Dana Nessel said the boy died within seconds after a single spark started a fire in the hyperbaric chamber he was in. Officials have not said yet what the cause of the fire was.
In a news conference Tuesday, Nessel accused Oxford Center staff of holding 'safety among their lowest considerations' but said officials had no way of knowing about the danger until it was too late, and cannot proactively investigate other facilities.
'Michigan law doesn't require any oversight over the use of hyperbaric chambers, so without having some sort of probable cause to believe that there are crimes being committed involving hyperbaric chambers in other places in the state, we wouldn't have the authority to go in and perform an inspection,' Nessel said.
The Oxford Center was subject to inspections every few years by the Troy Fire Department, said Michael Koehler, the fire department's deputy chief. He said the center applied for a permit when it opened, indicating it would be using hyperbaric chambers, and was last inspected in March 2023.
'But our inspections are fire- and life-safety focused,' Koehler said in a phone interview Friday. 'There's nothing that covers the operation or the maintenance of the chambers themselves.'
While hospitals that use hyperbaric chambers abide by codes developed by the National Fire Protection Association, a standards development organization, Michigan is not unique in lacking a regulatory framework for hyperbaric oxygen therapy outside of traditional health care facilities, said John Peters, executive director of the Undersea & Hyperbaric Medical Society, a nonprofit organization that accredits hospitals and freestanding facilities with hyperbaric chambers in the absence of government regulation.
At the moment, nearly 150 facilities across the country are accredited by the group, with two in Michigan.
The accreditation process involves on-site inspections and verification that equipment is maintained and specialists are properly trained, and costs about $10,000 for an accreditation that lasts for three to four years, Peters said.
He estimated that thousands of spas, wellness companies and other storefronts are operating hyperbaric chambers in the U.S. without having undergone accreditation, and he said he fears many may not be upholding stringent standards.
Two Democratic legislators in Michigan, state Sen. Stephanie Chang and state Rep. Sharon MacDonell, are working together to explore regulatory options after Thomas' death.
Chang said she was alarmed by what appeared to be a myriad of problems that led to the fire, based on what the Michigan attorney general outlined, including allegedly not having a properly trained technician operating the hyperbaric chamber.
'Let's fix all of those loopholes,' Chang said. She said she and MacDonell are aiming to introduce legislation in the spring.
MacDonell said it was important not just to make hyperbaric chambers safer but also to stop businesses from making unproven claims about what the therapy can do.
'People are taking advantage of parents with children with hard-to-treat conditions, and just kind of monetizing the desperation of the parents,' she said. 'It's just incomprehensible.'
Thomas' death comes as the use of hyperbaric oxygen therapy has proliferated, gaining steam in recent years thanks to celebrities who have touted it for everything from anti-aging to boosting their mental health. The FDA has warned that some claims about what hyperbaric chambers can do are 'unproven' and encourages patients to only go to accredited facilities.
Hyperbaric chamber fires are rare, but not unprecedented. In 2009, a 4-year-old and his grandmother died after a blaze at an unaccredited Florida clinic where the boy was receiving treatment for cerebral palsy. Two staff members were charged in their deaths, one of whom was a doctor who lost his medical license.
The 2009 case did not prompt national safety regulations, Peters said. He is hopeful that Thomas' death will.
'We desperately need mandatory accreditation,' he said. 'We're hoping that this will turn the page.'
While there are guidelines for how to safely construct and operate hyperbaric chambers, there is no consistent federal, state or local oversight of the practice outside of hospitals. The FDA said in an email last month that it regulates certain hyperbaric chambers that meet the agency's definition of Class II medical devices, which are 'intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease.' But it does not regulate the practice of medicine and referred NBC News to the Centers for Medicare & Medicaid Services, The Joint Commission and state medical licensing agencies for more information.
The Centers for Medicare & Medicaid Services requires Medicare and Medicaid providers to comply with parts of the National Fire Protection Association code, but that does not apply to other facilities, which must still adhere to local building and fire codes, said Brian O'Connor, a senior engineer at the National Fire Protection Association.
The Joint Commission, a nonprofit organization that accredits over 24,000 health care programs around the world, said in an email that it has emergency procedures and training drills for hospitals that have hyperbaric chambers but does not accredit places such as the Oxford Center.
Meanwhile, Michigan's health department, its occupational safety agency and the Department of Licensing and Regulatory Affairs all said they do not have oversight of hyperbaric chambers. The licensing agency said facilities using hyperbaric chambers are not required to be licensed, which Peters said was shocking.
'Why?' he said. 'Even a hairstylist has to have a license, and she's not going to blow up her whole salon.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify'
NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify'

Daily Mail​

timean hour ago

  • Daily Mail​

NHS patients battling Alzheimer's WON'T be offered 'miracle' drugs as health watchdog rules they are 'too expensive to justify'

Two of the first drugs proven to slow down Alzheimer's disease will be denied to NHS patients from this week - unless they pay to go private. The National Institute for Health and Care Excellence (NICE) has refused the 'miracle' drugs lecanemab and donanemab for use on the NHS as they are too expensive to justify. This means over 70,000 patients in England will be denied the 'game-changing' drugs, found to slow cognitive decline by an average of four to seven months, unless they can afford tens of thousands of pounds a year for private treatment. After a positive drug trial in 2022, lecanemab (brand name Leqembi) made by Eisai, and donanemab (marketed as Kisunla), made by Eli Lilly, were proven to clear toxic amyloid protein from the brain and thus slow the underlying cause of dementia. Campaigners hailed it as 'the beginning of the end' of Alzheimer's. Iain Hartnell, Research Communications Officer at Alzheimer's Society, said: 'The MHRA's approval of the first safe and effective Alzheimer's disease treatment, shown to slow progression, is a defining moment for people with early-stage Alzheimer's disease in the UK and a significant step towards a more hopeful future.' Last year, both drugs were given drug licences in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA). But without NICE's recommendation, the groundbreaking medicine will only be available to those with private healthcare. 'It is the end of the road for these drugs on the NHS,' an insider told The Times. Hilary Evans-Newton, the chief executive of Alzheimer's Research UK described the decision as 'deeply disappointing'. She told the publication that it sends 'a damaging signal to the life sciences sector - undermining confidence in the UK as a leader of dementia research, clinical trials and innovation, with knock-on effects for patients and the wider economy'. She added: 'These treatments are not perfect, and we recognise the challenges they pose around cost, delivery and safety. But scientific progress is incremental, and these drugs represent a vital foundation to build on.' The drugs were shown in trials to slow the rate of decline for those with mild to moderate Alzheimer's by an average of four to seven months. Lecanemab, for example, can slow the decline in memory and mental agility by 27 per cent in those with mild Alzheimer's taking the drug compared to people on the dummy drug. The research team also found that the drug reduced loss of quality of life by up to 56 per cent, according to the Alzheimer's Society. Importantly, the drug reduced the amount of amyloid protein present in the brain. Amyloid protein levels were also reduced in the blood and spinal fluid. Experts have long believed donanemab could herald a new era of dementia treatment, after studies showed it slowed the memory-robbing illness in its early stages Lecanemab has already been given the green light in the EU, US, China, Japan, Hong Kong, South Korea and Israel. It is estimated around 70,000 adults in England could eligible for the treatment if approved for use on the health service. Alzheimer's is the most common cause of dementia in the UK. Around 982,000 are currently estimated to be living with dementia UK - although this figure is expected to skyrocket to 1.4million in 2040. Alzheimer's Research UK analysis found 74,261 people died from dementia in 2022, compared to 69,178 a year earlier, making it the country's biggest killer. Recent analysis by the Alzheimer's Society estimates the overall annual cost of the dementia to the UK is £42billion a year, with families bearing the brunt. An ageing population means these costs — which include lost earnings of unpaid carers — are set to soar to £90billion in the next 15 years.

What is ‘gas station heroin' and why are health experts sounding the alarm over it?
What is ‘gas station heroin' and why are health experts sounding the alarm over it?

The Independent

time6 hours ago

  • The Independent

What is ‘gas station heroin' and why are health experts sounding the alarm over it?

'Gas station heroin' is rising in popularity and health officials are sounding the alarms of its potential consequences. The items are the brightly colored little bottles often sold at gas stations, convenience stores and smoke shops. They are usually marketed as energy shots or cognitive supplements but actually contain tianeptine, an unapproved drug that can be addictive and carries risks of serious side effects. U.S. poison control centers have reported a steady rise in calls linked to the drug for more than a decade. And last month the Food and Drug Administration sent a warning to health professionals about 'the magnitude of the underlying danger or these products.' Here's what to know about gas station heroin: How are these products sold in the U.S.? Tianeptine is approved in a number foreign countries as an antidepressant, usually as a low-dose pill taken three times a day. But it has never been approved by the FDA for any medical condition in the U.S. Additionally, the drug cannot legally be added to foods and beverages or sold as a dietary supplement — something the FDA has repeatedly warned U.S. companies about. Still, under-the-radar firms sell tianeptine in various formulas, often with brand names like Zaza, Tianaa, Pegasus and TD Red. Although that is technically illegal, the FDA does not preapprove ingredients added to supplements and beverages. 'It's kind of this grey area of consumer products, or supplements, where the contents are not regulated or tested the way they would be with a medication,' said Dr. Diane Calello of the New Jersey Poison Information and Education System. Last year, Calello and her colleagues published a study documenting a cluster of emergency calls in New Jersey tied to a flavored elixir called Neptune's Fix. People experienced distress, rapid heartbeat, low blood pressure and seizures after drinking it. More than a dozen of the 20 patients had to be admitted for intensive care. Why use these products? Many tianeptine products claim— without evidence or FDA approval— to help users treat medical conditions, including addiction, pain and depression. In 2018, the FDA issued a warning letter to the maker of a product called Tianna, which claimed to provide 'an unparalleled solution to cravings for opiates.' While tianeptine is not an opioid, the drug binds to some of the same receptors in the brain, which can temporarily produce effects akin to oxycodone and other opioids. Tianeptine also carries some of the same physiological risks of opioids, including the potential to dangerously depress breathing. 'That's what tends to get people into trouble,' said Dr. Hannah Hays of Nationwide Children's Hospital in Columbus, Ohio. 'They use it for opioid-like effects or to self-treat opioid withdrawal and that can lead to slow breathing and problems like that." People dealing with opioid addiction, pain, depression, anxiety and other conditions should see a health professional to get a prescription for FDA-approved treatments, Hays said. Is tianeptine use going up? Experts aren't sure but national figures show a big rise in emergency calls involving the drug. Calls to poison control centers increased 525% between 2018 and 2023, according to a data analysis published earlier this year. In about 40% of cases, the person had to seek medical care, with more than half of them needing critical care. One explanation for the rise in calls is simply that more Americans are using the products. But experts also say that the products are triggering more emergencies as they become more potent and dangerous. And the researchers in New Jersey who analyzed Neptune's Fix found that the liquid also contained synthetic cannabis and other drugs. 'You never quite know what's in that bottle," Calello said. 'It's important for people to know that even if they have used a product before, they could get a bottle that contains something very different from what they're looking for.' Are there policies that could reduce tianeptine use? Tianeptine is not included in the federal Controlled Substances Act, which bans or restricts drugs that have no medical use or have a high potential for abuse, such as heroin, LSD and PCP. But about a dozen states have passed laws prohibiting or restricting tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee. In some cases, those laws have led to more cases of withdrawal among users of tianeptine, which can be chemically addictive. But state data also shows some success in reducing harm tied to the drug. Until recently, Alabama had the highest rate of tianeptine-related calls in the southern U.S., which increased more than 1,400% between 2018 to 2021. But after the state restricted tianeptine in 2021 calls began modestly decreasing while calls across other southern states continued to climb.

'Gas station heroin' is technically illegal and widely available. Here are the facts
'Gas station heroin' is technically illegal and widely available. Here are the facts

The Independent

time12 hours ago

  • The Independent

'Gas station heroin' is technically illegal and widely available. Here are the facts

Health officials want you to think twice before buying one of those brightly colored little bottles often sold at gas stations, convenience stores and smoke shops. Sometimes called 'gas station heroin,' the products are usually marketed as energy shots or cognitive supplements but actually contain tianeptine, an unapproved drug that can be addictive and carries risks of serious side effects. U.S. poison control centers have reported a steady rise in calls linked to the drug for more than a decade. And last month the Food and Drug Administration sent a warning to health professionals about 'the magnitude of the underlying danger or these products.' Here's what to know about gas station heroin. How are these products sold in the U.S.? Tianeptine is approved in a number foreign countries as an antidepressant, usually as a low-dose pill taken three times a day. But it has never been approved by the FDA for any medical condition in the U.S. Additionally, the drug cannot legally be added to foods and beverages or sold as a dietary supplement — something the FDA has repeatedly warned U.S. companies about. Still, under-the-radar firms sell tianeptine in various formulas, often with brand names like Zaza, Tianaa, Pegasus and TD Red. Although that is technically illegal, the FDA does not preapprove ingredients added to supplements and beverages. 'It's kind of this grey area of consumer products, or supplements, where the contents are not regulated or tested the way they would be with a medication,' said Dr. Diane Calello of the New Jersey Poison Information and Education System. Last year, Calello and her colleagues published a study documenting a cluster of emergency calls in New Jersey tied to a flavored elixir called Neptune's Fix. People experienced distress, rapid heartbeat, low blood pressure and seizures after drinking it. More than a dozen of the 20 patients had to be admitted for intensive care. Why use these products? Many tianeptine products claim— without evidence or FDA approval— to help users treat medical conditions, including addiction, pain and depression. In 2018, the FDA issued a warning letter to the maker of a product called Tianna, which claimed to provide 'an unparalleled solution to cravings for opiates.' While tianeptine is not an opioid, the drug binds to some of the same receptors in the brain, which can temporarily produce effects akin to oxycodone and other opioids. Tianeptine also carries some of the same physiological risks of opioids, including the potential to dangerously depress breathing. 'That's what tends to get people into trouble,' said Dr. Hannah Hays of Nationwide Children's Hospital in Columbus, Ohio. 'They use it for opioid-like effects or to self-treat opioid withdrawal and that can lead to slow breathing and problems like that." People dealing with opioid addiction, pain, depression, anxiety and other conditions should see a health professional to get a prescription for FDA-approved treatments, Hays said. Is tianeptine use going up? Experts aren't sure but national figures show a big rise in emergency calls involving the drug. Calls to poison control centers increased 525% between 2018 and 2023, according to a data analysis published earlier this year. In about 40% of cases, the person had to seek medical care, with more than half of them needing critical care. One explanation for the rise in calls is simply that more Americans are using the products. But experts also say that the products are triggering more emergencies as they become more potent and dangerous. And the researchers in New Jersey who analyzed Neptune's Fix found that the liquid also contained synthetic cannabis and other drugs. 'You never quite know what's in that bottle," Calello said. 'It's important for people to know that even if they have used a product before, they could get a bottle that contains something very different from what they're looking for.' Are there policies that could reduce tianeptine use? Tianeptine is not included in the federal Controlled Substances Act, which bans or restricts drugs that have no medical use or have a high potential for abuse, such as heroin, LSD and PCP. But about a dozen states have passed laws prohibiting or restricting tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee. In some cases, those laws have led to more cases of withdrawal among users of tianeptine, which can be chemically addictive. But state data also shows some success in reducing harm tied to the drug. Until recently, Alabama had the highest rate of tianeptine-related calls in the southern U.S., which increased more than 1,400% between 2018 to 2021. But after the state restricted tianeptine in 2021 calls began modestly decreasing while calls across other southern states continued to climb. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store